Table 2.
Baseline characteristics of the subset of 80 women who had functional parameters measured up to 1 year after a hip fracture (m ± SD)
| Measure | All Subjects (n=80) | 25(OH)D ≤22.5 nmol/L [≤9 ng/mL (n=32)] | 25(OH)D >22.5 nmol/L [>9 ng/mL (n=48)] | p-value |
|---|---|---|---|---|
| a25-hydroxy Vitamin D (ng/mL) | 30.75 (21.5) | 15.25 (5.5) | 36.58 (22.0) | <0.001 |
| Age in years | 79.7 (8.0) | 80.8 (7.3) | 78.9 (8.4) | 0.32 |
| Pre-fracture | 1.64 (1.65) | 1.83 (1.83) | 1.51 (1.53) | 0.42 |
| Comorbidity | 1.79 (1.63) | 2.31 (1.96) | 1.44 (1.27) | 0.02 |
| BMI (kg/m2) | 23.5 (4.1) | 23.1 (4.5) | 23.8 (4.0) | 0.54 |
| Subcapital fracture | 53.8% | 37.5% | 65.2% | 0.02 |
| Arthroplasty | 47.4% | 46.7% | 47.8% | 0.92 |
a
To convert nmol/L to ng/mL multiply by 0.4